Registered number
07185445
Lisa Tan Pharma Consulting Limited
Filleted Accounts
31 March 2024
Lisa Tan Pharma Consulting Limited
Registered number: 07185445
Balance Sheet
as at 31 March 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 4 41,863 1,857
Current assets
Debtors 5 42,643 41,301
Cash at bank and in hand 825,570 737,306
868,213 778,607
Creditors: amounts falling due within one year 6 (50,540) (37,887)
Net current assets 817,673 740,720
Total assets less current liabilities 859,536 742,577
Provisions for liabilities (7,953) (236)
Net assets 851,583 742,341
Capital and reserves
Called up share capital 1 1
Profit and loss account 851,582 742,340
Shareholders' funds 851,583 742,341
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mrs E F Tan
Director
Approved by the board on 14 September 2024
Lisa Tan Pharma Consulting Limited
Notes to the Accounts
for the year ended 31 March 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Motor Vehicles 25%
Fixtures, fittings and equipment 20% - 33%
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Taxation 2024 2023
£ £
Corporation tax 33,811 34,619
Deferred tax 7,717 (107)
Adjustment to prior year (23) -
41,505 34,512
3 Employees 2024 2023
Number Number
Average number of persons employed by the company 1 1
4 Tangible fixed assets
Plant and machinery etc Motor vehicles Total
£ £ £
Cost
At 1 April 2023 11,633 - 11,633
Additions 665 53,791 54,456
At 31 March 2024 12,298 53,791 66,089
Depreciation
At 1 April 2023 9,776 - 9,776
Charge for the year 1,002 13,448 14,450
At 31 March 2024 10,778 13,448 24,226
Net book value
At 31 March 2024 1,520 40,343 41,863
At 31 March 2023 1,857 - 1,857
5 Debtors 2024 2023
£ £
Trade debtors 26,078 40,550
Other debtors 16,565 751
42,643 41,301
6 Creditors: amounts falling due within one year 2024 2023
£ £
Taxation and social security costs 49,613 34,824
Other creditors 927 3,063
50,540 37,887
7 Loans to directors
B/fwd Paid Repaid C/fwd
£ £ £ £
Mrs E F Tan
Dr K K C Tan
Directors loan account (2,180) 23,820 (5,861) 15,779
(2,180) 23,820 (5,861) 15,779
The loan to the directors, included in Other debtors, was repaid in full after the year end.
8 Other information
Lisa Tan Pharma Consulting Limited is a private company limited by shares and incorporated in England. Its registered office is:
Field House
Field Road
Kingston
Cambridgeshire
CB23 2NQ
Lisa Tan Pharma Consulting Limited 07185445 false 2023-04-01 2024-03-31 2024-03-31 VT Final Accounts April 2024 Mrs E F Tan No description of principal activity 07185445 2022-04-01 2023-03-31 07185445 core:WithinOneYear 2023-03-31 07185445 core:ShareCapital 2023-03-31 07185445 core:RetainedEarningsAccumulatedLosses 2023-03-31 07185445 2023-04-01 2024-03-31 07185445 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 07185445 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 07185445 bus:Director40 2023-04-01 2024-03-31 07185445 1 2023-04-01 2024-03-31 07185445 2 2023-04-01 2024-03-31 07185445 core:PlantMachinery 2023-04-01 2024-03-31 07185445 core:Vehicles 2023-04-01 2024-03-31 07185445 bus:Director1 2023-04-01 2024-03-31 07185445 bus:Director1 1 2023-04-01 2024-03-31 07185445 countries:England 2023-04-01 2024-03-31 07185445 bus:FRS102 2023-04-01 2024-03-31 07185445 bus:FilletedAccounts 2023-04-01 2024-03-31 07185445 2024-03-31 07185445 core:WithinOneYear 2024-03-31 07185445 core:ShareCapital 2024-03-31 07185445 core:RetainedEarningsAccumulatedLosses 2024-03-31 07185445 core:PlantMachinery 2024-03-31 07185445 core:Vehicles 2024-03-31 07185445 bus:Director1 1 2024-03-31 07185445 2023-03-31 07185445 core:PlantMachinery 2023-03-31 07185445 core:Vehicles 2023-03-31 07185445 bus:Director1 1 2023-03-31 iso4217:GBP xbrli:pure